Latest
New findings show COVID-19 vaccine reactions in people with MS are generally mild and short-lived.
We know research matters to you. This month, explore our top articles of the year – featuring the MS-gut connection and other fresh off the press findings in MS research.
- Jan 2025
Not enough time to read an entire newsletter? Our January newsletter snapshot contains the highlights in a quick, easy to read format.
- Jan 2025
Participate in a clinical trial evaluating a new immune cell therapy for MS, or a survey exploring MS and anxiety.
- Jan 2025
Did you know the Our Questions Have Power program lets you shape the future of MS research?
- Jan 2025
Your support enables iConquerMS to fuel groundbreaking research that directly addresses the needs and concerns of those living with MS.
- Jan 2025
Looking for ways to manage stress and improve your MS symptoms? Try painting – it might be just what you need!
The 2024 iConquerMS Summit spurred dynamic discussions that will lead to new initiatives in 2025!